<?xml version="1.0" encoding="UTF-8"?>
<p id="Par22">Advanced age, lymphopenia and recent allogenic stem cell transplantation have been recognized as general risk factors for the development of RSV lower respiratory tract infection [
 <xref ref-type="bibr" rid="CR10">10</xref>]. In particular, HSCT patients may be at risk of CMV reactivation, an infection that can result in multi-organ involvement and in an increased risk of graft-versus-host disease (GVHD) [
 <xref ref-type="bibr" rid="CR9">9</xref>].
</p>
